Solid Lymph Nodes as an Imaging Biomarker for Risk Stratification in Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma

References

1. 1.↵
   2. Gillison ML,
   3. Koch WM,
   4. Capone RB, et al

   . Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709–20 doi:10.1093/jnci/92.9.709 pmid:10793107

   Abstract/FREE Full Text
2. 2.↵
   2. Fakhry C,
   3. Westra WH,
   4. Li S, et al

   . Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100:261–69 doi:10.1093/jnci/djn011 pmid:18270337

   Abstract/FREE Full Text
3. 3.↵
   2. Ang KK,
   3. Harris J,
   4. Wheeler R, et al

   . Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24–35 doi:10.1056/NEJMoa0912217 pmid:20530316

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Mirghani H,
   3. Amen F,
   4. Blanchard P, et al

   . Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives. Int J Cancer 2015;136:1494–503 doi:10.1002/ijc.28847 pmid:24622970

   CrossRefPubMed
5. 5.↵
   2. Huang SH,
   3. Xu W,
   4. Waldron J, et al

   . Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas. J Clin Oncol 2015;33:836–45 doi:10.1200/JCO.2014.58.6412 pmid:25667292

   Abstract/FREE Full Text
6. 6.↵
   2. Horne ZD,
   3. Glaser SM,
   4. Vargo JA, et al

   . Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas. Cancer 2016;122:2021–30 doi:10.1002/cncr.30021 pmid:27111669

   CrossRefPubMed
7. 7.↵
   2. Huang SH,
   3. Perez-Ordonez B,
   4. Liu FF, et al

   . Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2012;82:276–83 doi:10.1016/j.ijrobp.2010.08.031 pmid:20950953

   CrossRefPubMed
8. 8.↵
   2. O'Sullivan B,
   3. Huang SH,
   4. Perez-Ordonez B, et al

   . Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation. Radiother Oncol 2012;103:49–56 doi:10.1016/j.radonc.2012.02.009 pmid:22410204

   CrossRefPubMed
9. 9.↵
   2. Spector ME,
   3. Gallagher KK,
   4. Light E, et al

   ; University of Michigan Head Neck Specialized Program of Research Excellence (SPORE) Program. Matted nodes: poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR status. Head Neck 2012;34:1727–33 doi:10.1002/hed.21997 pmid:22247002

   CrossRefPubMed
10. 10.↵
    2. Kaka AS,
    3. Kumar B,
    4. Kumar P, et al

    . Highly aggressive human papillomavirus-related oropharyngeal cancer: clinical, radiologic, and pathologic characteristics. Oral Surg Oral Med Oral Pathol Oral Radiol 2013;116:327–35 doi:10.1016/j.oooo.2013.04.011 pmid:23770280

    CrossRefPubMed
11. 11.↵
    2. Goldenberg D,
    3. Begum S,
    4. Westra WH, et al

    . Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck 2008;30:898–903 doi:10.1002/hed.20796 pmid:18383529

    CrossRefPubMed
12. 12.↵
    2. Morani AC,
    3. Eisbruch A,
    4. Carey TE, et al

    . Intranodal cystic changes: a potential radiologic signature/biomarker to assess the human papillomavirus status of cases with oropharyngeal malignancies. J Comput Assist Tomogr 2013;37:343–45 doi:10.1097/RCT.0b013e318282d7c3 pmid:23674003

    CrossRefPubMed
13. 13.↵
    2. Chiosea SI,
    3. Grandis JR,
    4. Lui VW, et al

    . PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma. BMC Cancer 2013;13:602 doi:10.1186/1471-2407-13-602 pmid:24341335

    CrossRefPubMed
14. 14.↵
    2. Maxwell JH,
    3. Ferris RL,
    4. Gooding W, et al

    . Extracapsular spread in head and neck carcinoma: impact of site and human papillomavirus status. Cancer 2013;119:3302–08 doi:10.1002/cncr.28169 pmid:23797868

    CrossRefPubMed
15. 15.↵
    2. Edge SB,
    3. Byrd DR,
    4. Compton CC, et al.

    , eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010:41–56
16. 16.↵
    2. Alluri KC,
    3. Tahari AK,
    4. Wahl RL, et al

    . Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma. AJR Am J Roentgenol 2014;203:897–903 doi:10.2214/AJR.14.12497 pmid:25247958

    CrossRefPubMed
17. 17.↵
    2. Kubicek GJ,
    3. Champ C,
    4. Fogh S, et al

    . FDG-PET staging and importance of lymph node SUV in head and neck cancer. Head Neck Oncol 2010;2:19 doi:10.1186/1758-3284-2-19 pmid:20637102

    CrossRefPubMed
18. 18.↵
    2. Cheng NM,
    3. Chang JT,
    4. Huang CG, et al

    . Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma. Eur J Nucl Med Mol Imaging 2012;39:1673–84 doi:10.1007/s00259-012-2186-9 pmid:22854984

    CrossRefPubMed
19. 19.↵
    2. Davis KS,
    3. Lim CM,
    4. Clump DA, et al

    . Tumor volume as a predictor of survival in human papillomavirus-positive oropharyngeal cancer. Head Neck 2016;38(suppl 1):E1613–17 doi:10.1002/hed.24287 pmid:26681273

    CrossRefPubMed
20. 20.↵
    2. Chai RL,
    3. Rath TJ,
    4. Johnson JT, et al

    . Accuracy of computed tomography in the prediction of extracapsular spread of lymph node metastases in squamous cell carcinoma of the head and neck. JAMA Otolaryngol Head Neck Surg 2013;139:1187–94 doi:10.1001/jamaoto.2013.4491 pmid:24076619

    CrossRefPubMed
21. 21.↵
    2. Branstetter BF,
    3. Rath TJ,
    4. Kubicek GJ

    . Accuracy of computed tomography for predicting pathologic nodal extracapsular extension in patients with head and neck cancer undergoing initial surgical resection: in regard to Prabhu, et al. Int J Radiat Oncol Biol Phys 2014;89:434–35 doi:10.1016/j.ijrobp.2014.02.009 pmid:24837895

    CrossRefPubMed
22. 22.↵
    2. Prabhu RS,
    3. Magliocca KR,
    4. Hanasoge S, et al

    . Accuracy of computed tomography for predicting pathologic nodal extracapsular extension in patients with head-and-neck cancer undergoing initial surgical resection. Int J Radiat Oncol Biol Phys 2014;88:122–29 doi:10.1016/j.ijrobp.2013.10.002 pmid:24331658

    CrossRefPubMed
23. 23.↵
    2. Maxwell JH,
    3. Rath TJ,
    4. Byrd JK, et al

    . Accuracy of computed tomography to predict extracapsular spread in p16-positive squamous cell carcinoma. Laryngoscope 2015;125:1613–18 doi:10.1002/lary.25140 pmid:25946149

    CrossRefPubMed
24. 24.↵
    2. Liu JT,
    3. Kann BH,
    4. De B, et al

    . Prognostic value of radiographic extracapsular extension in locally advanced head and neck squamous cell cancers. Oral Oncol 2016;52:52–57 doi:10.1016/j.oraloncology.2015.11.008 pmid:26728104

    CrossRefPubMed
25. 25.↵
    2. Joo YH,
    3. Cho KJ,
    4. Park JO, et al

    . High-risk human papillomavirus and lymph node size in patients with single node metastasis of oral and oropharyngeal cancer. Acta Otolaryngol 2014;134:395–400 doi:10.3109/00016489.2013.844364 pmid:24628336

    CrossRefPubMed
26. 26.↵
    2. Maxwell JH,
    3. Kumar B,
    4. Feng FY, et al

    . Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res 2010;16:1226–35 doi:10.1158/1078-0432.CCR-09-2350 pmid:20145161

    Abstract/FREE Full Text
27. 27.↵
    2. Gillison ML,
    3. Zhang Q,
    4. Jordan R, et al

    . Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 2012;30:2102–11 doi:10.1200/JCO.2011.38.4099 pmid:22565003

    Abstract/FREE Full Text
28. 28.↵
    2. O'Sullivan B,
    3. Huang SH,
    4. Siu LL, et al

    . Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol 2013;31:543–50 doi:10.1200/JCO.2012.44.0164 pmid:23295795

    Abstract/FREE Full Text